1533 A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: efficacy and safety results from the open-label phase 2 SCOPE trial

• Miranda Payne,
• Sarah Danson,
• Satish Kumar,
• Poulam Patel,
• Heather Shaw,
• Robert Miller,
• Martin Highley,
• Clare Barlow,
• Fayaz Master,
• Lindy Durrant

Affiliations

Miranda Payne

4Churchill Hospital, Oxford University Hospitals, Oxford, Oxfordshire, UK

Sarah Danson

6Weston Park Cancer Centre, Sheffield Teaching Hospital NHS Trust, Sheffield, Sheffield, UK

Satish Kumar

5Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, UK

Poulam Patel

3Nottingham Hospitals University Trust, Nottingham, Nottinghamshire, UK

Heather Shaw

1Mount Vernon Cancer Centre, Northwood, Hertfordshire, UK

Robert Miller

9Scancell Ltd, Oxford, Oxfordshire, UK

Martin Highley

7Derriford Hospital, University Hospitals NHS Trust, Plymouth, Devonshire, UK

Clare Barlow

8Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton, Somerset, UK

Fayaz Master

9Scancell Ltd, Oxford, Oxfordshire, UK

Lindy Durrant

9Scancell Ltd, Oxford, Oxfordshire, UK